GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Unjha Formulations Ltd (BOM:531762) » Definitions » 5-Year EBITDA Growth Rate

Unjha Formulations (BOM:531762) 5-Year EBITDA Growth Rate : 6.10% (As of Sep. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Unjha Formulations 5-Year EBITDA Growth Rate?

Unjha Formulations's EBITDA per Share for the three months ended in Sep. 2024 was ₹-0.19.

During the past 3 years, the average EBITDA Per Share Growth Rate was 19.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 6.10% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 7.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Unjha Formulations was 37.80% per year. The lowest was -3.30% per year. And the median was 9.85% per year.


Competitive Comparison of Unjha Formulations's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Unjha Formulations's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Unjha Formulations's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Unjha Formulations's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Unjha Formulations's 5-Year EBITDA Growth Rate falls into.



Unjha Formulations 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Unjha Formulations  (BOM:531762) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Unjha Formulations 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Unjha Formulations's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Unjha Formulations Business Description

Traded in Other Exchanges
N/A
Address
Khali Char Rasta, State Highway, Sidhpur, Khali, Patan, GJ, IND, 384151
Unjha Formulations Ltd is an India-based manufacturer and exporter of Ayurvedic products. The company products include Isabgol powder under the Fibron and Fibron SF name, and Sat-Isabgol and Isabgol Husk. It also offers human and veterinary medicines.

Unjha Formulations Headlines

No Headlines